Literature DB >> 33425304

Medication-Related Osteonecrosis of the Jaw and Low-Level Laser Therapy as Adjuvant Treatment: A Case Report.

Amanda Azevedo Torres1, Beatriz Leal de Freitas2, Patrick Parry Carneiro2, André Luca Araujo de Sousa2, Maria Ângela Arêa Leão Ferraz3, Jean de Pinho Mendes4, André Luiz Ferreira Costa5, Antonione Santos Bezerra Pinto6.   

Abstract

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) occurs by the use of a drug that has osteonecrosis as one of its side effects. Case Report: We describe a case of a 48-year-old oncological patient who had brain and bone metastasis due to breast cancer and was medicated with bisphosphonates (BPs). She presented cavities, and after an incorrect exodontia, the lesion evolved into a jaw osteonecrosis. Then she did a sequestrectomy and was treated using laser therapy. Radiological and clinical features are also described.
Conclusion: In a case like this, we notice how necessary is a complete evaluation of the oncological patient before some procedures and laser therapy as an effective ally in the management.
Copyright © 2020 J Lasers Med Sci.

Entities:  

Keywords:  Bisphosphonate-associated osteonecrosis of the jaw; Laser therapy; Low-level Light therapy

Year:  2020        PMID: 33425304      PMCID: PMC7736937          DOI: 10.34172/jlms.2020.78

Source DB:  PubMed          Journal:  J Lasers Med Sci        ISSN: 2008-9783


  2 in total

1.  An Evaluation of the Effects of Photobiomodulation Therapy on the Peri-Implant Bone Healing of Implants with Different Surfaces: An In Vivo Study.

Authors:  Pier Paolo Poli; Laís Kawamata de Jesus; Ulisses Ribeiro Campos Dayube; Henrique Hadad; Caroline Loureiro; Fernando Yamamoto Chiba; Thayane Silveira Mata Furtado; Maísa Pereira Silva; Roberta Okamoto; Carlo Maiorana; Paulo Sergio Perri de Carvalho; Francisley Ávila Souza
Journal:  Materials (Basel)       Date:  2022-06-21       Impact factor: 3.748

2.  Bioinformatic Data Mining for Candidate Drugs Affecting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) in Cancer Patients.

Authors:  Jinpeng Zhuang; Jianing Zu; Changlong Zhou; Yi Sun; Pengyu Kong; Yongbin Jing
Journal:  Dis Markers       Date:  2022-09-14       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.